reviewTop 10% cited
Targeting p38 MAPK pathway for the treatment of Alzheimer's disease
Neuropharmacology · 2009 · Vol. 58(3) · pp. 561–568
Lenka Munoz✉(University of Sydney)Alaina J. Ammit(University of Sydney)
Alzheimer's disease research and treatmentsCholinesterase and Neurodegenerative DiseasesMelanoma and MAPK PathwaysMAPK/ERK pathwayExcitotoxicityNeurosciencep38 mitogen-activated protein kinasesNeuroinflammationNeurodegenerationProtein kinase ADiseaseAlzheimer's diseaseMedicine
MeSH terms
Alzheimer DiseaseEnzyme InhibitorsHumansModels, BiologicalNeuronal PlasticityPhosphorylationAntipsychotic AgentsSignal Transductionp38 Mitogen-Activated Protein Kinases
Funding
- Deutscher Akademischer Austauschdienst
Citations
363
FWCI
7.09
field-weighted impact
References
120
Percentile
98%
vs. same field & year
Citations per year
References
Intracellular amyloid-β in Alzheimer's disease
Nature reviews. Neuroscience · 2007 · 1,900 citations
A synaptic model of memory: long-term potentiation in the hippocampus
Nature · 1993 · 11,490 citations
The Amyloid Hypothesis of Alzheimer's Disease: Progress and Problems on the Road to Therapeutics
Science · 2002 · 13,715 citations
MAPKs and their relevance to arthritis and inflammation
Lara D. Veeken · 2007 · 462 citations
Inflammation and Alzheimer's disease
Neurobiology of Aging · 2000 · 4,492 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.